IPP Bureau
JP Nadda highlights preventive healthcare push on World Health Day
By IPP Bureau - April 08, 2026
Union Health Minister says India’s healthcare model blends traditional wisdom with modern science, backed by Ayushman Bharat and Janaushadhi expansion
Asia emerges new hotspot for healthcare ransomware, says report
By IPP Bureau - April 08, 2026
Cyble’s 2026 healthcare threat report flags a sharp rise in Asia-focused ransomware, with hospitals, elderly care, and diagnostic systems increasingly in cybercriminal crosshairs
Solara Active Pharma dispatches final rights share call notice; Rs 112.5 per share due by May 7
By IPP Bureau - April 08, 2026
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
Dabur reports steady domestic growth amid global headwinds in Q4 FY26
By IPP Bureau - April 08, 2026
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
Trialt and Viedoc team up to transform clinical trials
By IPP Bureau - April 08, 2026
The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide
IndiaAI, CDSCO launch hackathon to accelerate health innovation approvals
By IPP Bureau - April 08, 2026
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
Transgene and NEC join forces to advance personalized cancer vaccine
By IPP Bureau - April 08, 2026
TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor
Alpha Cognition secures key US patent for traumatic brain injury treatment
By IPP Bureau - April 08, 2026
The patent, titled “ALPHA-1062 for treating Traumatic Brain Injury,” strengthens Alpha Cognition’s existing portfolio supporting both ALPHA-1062 and ZUNVEYL
Regeneron and TriNetX forge $200M partnership to supercharge drug discovery and digital health
By IPP Bureau - April 08, 2026
TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
WHO updates global guidelines to combat opioid crisis
By IPP Bureau - April 08, 2026
Opioid dependence remains a major driver of death and disease worldwide
OneCyte and Kemp Proteins to revolutionize cell line development
By IPP Bureau - April 08, 2026
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
Moderna to reveal late-breaking data on flu & RSV mRNA vax at ESCMID 2026
By IPP Bureau - April 08, 2026
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
Neurocrine Biosciences to acquire Soleno Therapeutics for $2.9 billion
By IPP Bureau - April 08, 2026
The acquisition adds VYKAT XR (diazoxide choline), the first FDA-approved therapy for hyperphagia in Prader-Willi syndrome (PWS), a rare genetic disorder, to Neurocrine’s portfolio
ImmunityBio responds to FDA concerns over promotional content
By IPP Bureau - April 08, 2026
